Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
Onkologie|June 1, 1979
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study]M Dietrich, C Abt, R Arnold, et al.
Haematologica|May 9, 2000
Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?A Iolascon, V Servedio, R Carbone, et al.
Blut|October 1, 1985
Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood productsV Erfle, R Hehlmann, W Mellert, et al.
Blood|July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
The New England Journal of Medicine|May 9, 1991
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study GroupN Frickhofen, J P Kaltwasser, H Schrezenmeier, et al.
Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.
Blood|December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
Onkologie|February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]R Hehlmann, H Heimpel, D K Hossfeld, et al.
Klinische Wochenschrift|June 15, 1984
[Bone marrow transplantation in panmyelopathy, acute leukemia and chronic myelocytic leukemia: results of the Ulm Transplantation Group]R Arnold, T Schmeiser, W Friedrich, et al.
Leukemia & Lymphoma|January 1, 1993
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1R Hehlmann, H Heimpel, H J Kolb, et al.
Pageof 27